Pharma-Bio Serv (PBSV) Cash & Equivalents Growth (1y) (2011 - 2026)
Pharma-Bio Serv (PBSV) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn | -3.48% |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn | 1,598.22% |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn | -7.82% |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn | -35.29% |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn | 4.56% |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn | 30.03% |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn | -84.67% |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn | -10.61% |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn | -54.79% |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | -21.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -21.12% |
| Oct 31, 2025 | -50.07% |
| Jul 31, 2025 | -39.30% |
| Apr 30, 2025 | -40.36% |
| Jan 31, 2025 | 13.93% |
| Oct 31, 2024 | -35.22% |
| Jul 31, 2024 | 127.22% |
| Apr 30, 2024 | -56.65% |
| Jan 31, 2024 | -11.23% |
| Oct 31, 2023 | -27.77% |
| Jul 31, 2023 | -79.85% |
| Apr 30, 2023 | -38.50% |
| Jan 31, 2023 | -52.93% |
| Oct 31, 2022 | -17.21% |
| Jul 31, 2022 | -13.69% |
| Apr 30, 2022 | -18.07% |
| Jan 31, 2022 | -19.15% |
| Oct 31, 2021 | 1.93% |
| Jul 31, 2021 | -1.88% |
| Apr 30, 2021 | 3.11% |